DNA gyrase as a drug target

被引：95

作者：

Maxwell, A ^{[1
]}

机构：

[1] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England

来源：

BIOCHEMICAL SOCIETY TRANSACTIONS | 1999年 / 27卷 / 02期

基金：

英国惠康基金;

关键词：

D O I：

10.1042/bst0270048

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

收藏

页码：48 / 53

页数：6

相关论文

共 34 条

[1] THE 43-KILODALTON N-TERMINAL FRAGMENT OF THE DNA GYRASE-B PROTEIN HYDROLYZES ATP AND BINDS COUMARIN DRUGS
ALI, JA
JACKSON, AP
HOWELLS, AJ
MAXWELL, A
[J]. BIOCHEMISTRY, 1993, 32 (10) : 2717 - 2724
[2] Bates A. D., 1993, DNA topology
[3] Crystal structure of the breakage-reunion domain of DNA gyrase
Cabral, JHM
Jackson, AP
Smith, CV
Shikotra, N
Maxwell, A
Liddington, RC
[J]. NATURE, 1997, 388 (6645) : 903 - 906
[4] LOCAL SEQUENCE REQUIREMENTS FOR DNA CLEAVAGE BY MAMMALIAN TOPOISOMERASE-II IN THE PRESENCE OF DOXORUBICIN
CAPRANICO, G
KOHN, KW
POMMIER, Y
[J]. NUCLEIC ACIDS RESEARCH, 1990, 18 (22) : 6611 - 6619
[5] CONTRERAS A, 1992, MOL MICROBIOL, V6, P1617
[6] DNA cleavage is not required for the binding of quinolone drugs to the DNA Gyrase - DNA complex
Critchlow, SE
Maxwell, A
[J]. BIOCHEMISTRY, 1996, 35 (23) : 7387 - 7393
[7] DNA gyrase, topoisomerase IV, and the 4-quinolones
Drlica, K
Zhao, XL
[J]. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 1997, 61 (03) : 377 - +
[8] DIFFERENTIAL-EFFECTS OF ANTIBIOTICS INHIBITING GYRASE
ENGLE, EC
MANES, SH
DRLICA, K
[J]. JOURNAL OF BACTERIOLOGY, 1982, 149 (01) : 92 - 98
[9] EVERETT MJ, 1997, HDB PHARM QUINOLONE, P259
[10] MUTATIONAL ANALYSIS OF A TYPE-II TOPOISOMERASE CLEAVAGE SITE - DISTINCT REQUIREMENTS FOR ENZYME AND INHIBITORS
FREUDENREICH, CH
KREUZER, KN
[J]. EMBO JOURNAL, 1993, 12 (05) : 2085 - 2097

← 1 2 3 4 →